Bisacodyl: Indication, Dosage, Side Effect, Precaution

Generic Medicine Info Full Generic Medicine Info

Dosage/Direction for Use Administration Contraindications Special Precautions Adverse Reactions Pregnancy Category (US FDA) Overdosage Drug Interactions Food Interaction Action Storage CIMS Class ATC Classification

This information is not country-specific. Please refer to the India prescribing information.

Generic Medicine Info

Administration

Should be taken on an empty stomach. Take on an empty stomach for rapid effect. Do not take w/in 1 hr of antacids, milk or other dairy products.

Contraindications

Ileus, intestinal obstruction, acute surgical abdominal conditions (e.g. appendicitis, acute inflammatory bowel disease, severe abdominal pain associated with nausea and vomiting), severe dehydration. Rectal: Anal fissures, proctitis or ulcerated haemorrhoids.

Special Precautions

Children. Pregnancy and lactation. Avoid prolonged use (>5 days). Patient Counselling This drug may cause dizziness or syncope, if affected, do not drive or operate machinery.

Adverse Reactions

Significant: Fluid and electrolyte imbalance, hypokalaemia (prolonged use). Gastrointestinal disorders: Abdominal pain, abdominal cramps, nausea, diarrhoea, vomiting, haematochezia, abdominal discomfort, anorectal discomfort, rectal burning (suppository). Rarely, colitis. Metabolism and nutrition disorders: Rarely, dehydration. Nervous system disorders: Dizziness. Rarely, syncope.

Pregnancy Category (US FDA)

Drug Interactions

High dose of bisacodyl may increase the risk of electrolyte imbalance with concomitant use of diuretics or adrenocorticosteroids. Enhanced gastrointestinal adverse effects with concomitant use of other laxatives. Decreased therapeutic effect and increased risk of dyspepsia and gastric irritation with concomitant use of antacids.

CIMS Class

Laxatives, Purgatives

ATC Classification

A06AB02 - bisacodyl ; Belongs to the class of contact laxatives.
A06AG02 - bisacodyl ; Belongs to the class of enemas. Used in the treatment of constipation.

Disclaimer: This information is independently developed by CIMS based on bisacodyl from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 CIMS. All rights reserved. Powered by CIMSAsia.com